Caseware UK (AP4) 2022.0.179 2022.0.179 2023-03-312023-03-317falseNo description of principal activitytruetrue2022-04-018The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 10981723 2022-04-01 2023-03-31 10981723 2021-04-01 2022-03-31 10981723 2023-03-31 10981723 2022-03-31 10981723 1 2022-04-01 2023-03-31 10981723 d:Director1 2022-04-01 2023-03-31 10981723 c:PlantMachinery 2022-04-01 2023-03-31 10981723 c:PlantMachinery 2023-03-31 10981723 c:PlantMachinery 2022-03-31 10981723 c:PlantMachinery c:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 10981723 c:ComputerEquipment 2022-04-01 2023-03-31 10981723 c:ComputerEquipment 2023-03-31 10981723 c:ComputerEquipment 2022-03-31 10981723 c:ComputerEquipment c:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 10981723 c:OwnedOrFreeholdAssets 2022-04-01 2023-03-31 10981723 c:Goodwill 2022-04-01 2023-03-31 10981723 c:Goodwill 2023-03-31 10981723 c:Goodwill 2022-03-31 10981723 c:CurrentFinancialInstruments 2023-03-31 10981723 c:CurrentFinancialInstruments 2022-03-31 10981723 c:Non-currentFinancialInstruments 2023-03-31 10981723 c:Non-currentFinancialInstruments 2022-03-31 10981723 c:CurrentFinancialInstruments c:WithinOneYear 2023-03-31 10981723 c:CurrentFinancialInstruments c:WithinOneYear 2022-03-31 10981723 c:Non-currentFinancialInstruments c:AfterOneYear 2023-03-31 10981723 c:Non-currentFinancialInstruments c:AfterOneYear 2022-03-31 10981723 c:ShareCapital 2023-03-31 10981723 c:ShareCapital 2022-03-31 10981723 c:RetainedEarningsAccumulatedLosses 2023-03-31 10981723 c:RetainedEarningsAccumulatedLosses 2022-03-31 10981723 d:OrdinaryShareClass1 2022-04-01 2023-03-31 10981723 d:OrdinaryShareClass1 2023-03-31 10981723 d:FRS102 2022-04-01 2023-03-31 10981723 d:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 10981723 d:FullAccounts 2022-04-01 2023-03-31 10981723 d:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 10981723 c:AcceleratedTaxDepreciationDeferredTax 2023-03-31 10981723 c:AcceleratedTaxDepreciationDeferredTax 2022-03-31 10981723 c:Goodwill c:OwnedIntangibleAssets 2022-04-01 2023-03-31 xbrli:shares iso4217:GBP xbrli:pure



Company Registration No. 10981723 (England and Wales)







LAMERTONS EYECARE LIMITED

UNAUDITED
FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 31 MARCH 2023



































Riordan O'Sullivan & Co
Chartered Certified Accountants
40 Chamberlayne Road
London
NW10 3JE

 
LAMERTONS EYECARE LIMITED
REGISTERED NUMBER:10981723

BALANCE SHEET
AS AT 31 MARCH 2023

2023
2022
Note
£
£

Fixed assets
  

Intangible assets
 4 
360,500
432,600

Tangible assets
 5 
101,893
23,297

  
462,393
455,897

Current assets
  

Stocks
  
40,000
18,000

Debtors: amounts falling due within one year
 6 
9,507
110,681

Cash at bank and in hand
  
544,022
217,648

  
593,529
346,329

Creditors: amounts falling due within one year
 7 
(268,043)
(243,289)

Net current assets
  
 
 
325,486
 
 
103,040

Total assets less current liabilities
  
787,879
558,937

Creditors: amounts falling due after more than one year
 8 
(18,103)
-

Provisions for liabilities
  

Deferred tax
 9 
(16,971)
(1,513)

  
 
 
(16,971)
 
 
(1,513)

Net assets
  
752,805
557,424


Capital and reserves
  

Called up share capital 
 10 
100
100

Profit and loss account
  
752,705
557,324

  
752,805
557,424


Page 1

 
LAMERTONS EYECARE LIMITED
REGISTERED NUMBER:10981723
    
BALANCE SHEET (CONTINUED)
AS AT 31 MARCH 2023

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 4 September 2023.




___________________________
Richard Harold Kennedy
Director

Page 2

 
LAMERTONS EYECARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1.


General information

Lamertons Eyecare Limited is a private company limited by shares incorporated in England and Wales. The registered office is 40 Chamberlayne Road, London, NW10 3JE.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

 
2.3

Turnover

Turnover represents amounts chargeable net of value added tax, in respect of optician services and related sale of goods. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

 
2.4

Government grants

Grants are accounted under the accruals model as permitted by FRS 102. Grants relating to expenditure on tangible fixed assets are credited to profit or loss at the same rate as the depreciation on the assets to which the grant relates. The deferred element of grants is included in creditors as deferred income.
Grants of a revenue nature are recognised in the Profit and Loss Account in the same period as the related expenditure.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 3

 
LAMERTONS EYECARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

 
2.8

Intangible assets

Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. 
Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years. This length of time is presumed to be the maximum useful life of purchased goodwill as it is difficult to make projections beyond this period.

 The estimated useful lives range as follows:

Goodwill
-
10
years

 
2.9

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, on a reducing balance basis.

Depreciation is provided on the following basis:

Plant and machinery
-
25%
reducing balance
Computer equipment
-
25%
reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.10

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowances for obsolete and slow moving items. Cost includes all cost of purchases, cost of conversion and other costs incurred in bringing the stocks to their present location and condition. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

Page 4

 
LAMERTONS EYECARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

2.Accounting policies (continued)

 
2.11

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.12

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.13

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance Sheet.

 
2.14

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 7 (2022 - 8).

Page 5

 
LAMERTONS EYECARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

4.


Intangible assets




Goodwill

£



Cost


At 1 April 2022
721,000



At 31 March 2023

721,000



Amortisation


At 1 April 2022
288,400


Charge for the year on owned assets
72,100



At 31 March 2023

360,500



Net book value



At 31 March 2023
360,500



At 31 March 2022
432,600



Page 6

 
LAMERTONS EYECARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

5.


Tangible fixed assets





Plant and machinery
Computer equipment
Total

£
£
£



Cost or valuation


At 1 April 2022
69,253
4,379
73,632


Additions
102,310
-
102,310



At 31 March 2023

171,563
4,379
175,942



Depreciation


At 1 April 2022
47,341
2,994
50,335


Charge for the year on owned assets
23,368
346
23,714



At 31 March 2023

70,709
3,340
74,049



Net book value



At 31 March 2023
100,854
1,039
101,893



At 31 March 2022
21,912
1,385
23,297


6.


Debtors

2023
2022
£
£


Trade debtors
9,507
10,681

Other debtors
-
100,000

9,507
110,681


Page 7

 
LAMERTONS EYECARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

7.


Creditors: Amounts falling due within one year

2023
2022
£
£

Trade creditors
17,042
10,447

Corporation tax
49,994
88,403

Other taxation and social security
14,590
19,665

Obligations under finance lease and hire purchase contracts
5,419
-

Directors loan account
156,998
97,386

Accruals
24,000
27,388

268,043
243,289



8.


Creditors: Amounts falling due after more than one year

2023
2022
£
£

Net obligations under finance leases and hire purchase contracts
18,103
-



9.


Deferred taxation




2023


£






At beginning of year
(1,513)


Charged to profit or loss
(15,458)



At end of year
(16,971)

The provision for deferred taxation is made up as follows:

2023
2022
£
£


Accelerated capital allowances
16,971
1,513


10.


Share capital

2023
2022
£
£
Allotted, called up and fully paid



100 Ordinary shares of £1.00 each
100
100


Page 8

 
LAMERTONS EYECARE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

11.


Profit and loss account

2023
2022
£
£



Brought forward
557,324
308,791

Profit for the year
225,381
278,533

Dividends payable
(30,000)
(30,000)

752,705
557,324


12.


Post balance sheet events

There were no events since the year end which materially affected the company.


13.


Controlling party

Richard Kennedy owns 100% of the issued share capital of the company and is therefore the ultimate controller of the company.

 
Page 9